PharmaResources (China) Price on October 8, 2024
| 301230 Stock | 27.00 0.62 2.24% |
If you're considering investing in PharmaResources Stock, it is important to understand the factors that can impact its price. As of today, the current price of PharmaResources stands at 27.00, as last reported on the 18th of December 2024, with the highest price reaching 27.47 and the lowest price hitting 26.21 during the day. PharmaResources appears to be somewhat reliable, given 3 months investment horizon. PharmaResources maintains Sharpe Ratio (i.e., Efficiency) of 0.14, which implies the firm had a 0.14% return per unit of risk over the last 3 months. By analyzing PharmaResources' technical indicators, you can evaluate if the expected return of 0.71% is justified by implied risk. Please evaluate PharmaResources' Coefficient Of Variation of 812.72, semi deviation of 4.39, and Risk Adjusted Performance of 0.0977 to confirm if our risk estimates are consistent with your expectations.
PharmaResources Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
PharmaResources |
Sharpe Ratio = 0.1433
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 301230 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.98 actual daily | 44 56% of assets are more volatile |
Expected Return
| 0.71 actual daily | 14 86% of assets have higher returns |
Risk-Adjusted Return
| 0.14 actual daily | 11 89% of assets perform better |
Based on monthly moving average PharmaResources is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of PharmaResources by adding it to a well-diversified portfolio.
Price Book 3.691 | Enterprise Value Ebitda 969.6189 | Price Sales 7.3337 | Shares Float 46 M | Dividend Share 0.354 |
PharmaResources Valuation on October 8, 2024
It is possible to determine the worth of PharmaResources on a given historical date. On October 8, 2024 PharmaResources was worth 28.99 at the beginning of the trading date compared to the closed value of 27.96. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of PharmaResources stock. Still, in general, we apply an absolute valuation method to find PharmaResources' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of PharmaResources where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against PharmaResources' related companies.
| Open | High | Low | Close | Volume | |
| 23.75 | 25.67 | 22.36 | 25.05 | 8,513,595 | |
10/08/2024 | 28.99 | 28.99 | 25.06 | 27.96 | 9,441,759 |
| 26.64 | 26.90 | 23.91 | 24.00 | 6,318,560 |
| Backtest PharmaResources | | | PharmaResources History | | | PharmaResources Valuation | Previous | Next |
PharmaResources Trading Date Momentum on October 8, 2024
The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.PharmaResources Fundamentals Correlations and Trends
By evaluating PharmaResources' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among PharmaResources' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. PharmaResources financial account trend analysis is a perfect complement when working with valuation or volatility modules.About PharmaResources Stock history
PharmaResources investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for PharmaResources is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in PharmaResources will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing PharmaResources stock prices may prove useful in developing a viable investing in PharmaResources
PharmaResources Stock Technical Analysis
PharmaResources technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
PharmaResources Period Price Range
Low | December 18, 2024
| High |
0.00 | 0.00 |
PharmaResources Co Ltd cannot be verified against its exchange. Please verify the symbol is currently traded on Shenzhen Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
PharmaResources December 18, 2024 Market Strength
Market strength indicators help investors to evaluate how PharmaResources stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading PharmaResources shares will generate the highest return on investment. By undertsting and applying PharmaResources stock market strength indicators, traders can identify PharmaResources Co Ltd entry and exit signals to maximize returns
PharmaResources Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for PharmaResources' price direction in advance. Along with the technical and fundamental analysis of PharmaResources Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of PharmaResources to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0977 | |||
| Jensen Alpha | 0.6664 | |||
| Total Risk Alpha | 0.1969 | |||
| Sortino Ratio | 0.1072 | |||
| Treynor Ratio | (0.37) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for PharmaResources Stock analysis
When running PharmaResources' price analysis, check to measure PharmaResources' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PharmaResources is operating at the current time. Most of PharmaResources' value examination focuses on studying past and present price action to predict the probability of PharmaResources' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PharmaResources' price. Additionally, you may evaluate how the addition of PharmaResources to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |